Comparison of once-daily glargine insulin with twice-daily NPH/Regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery

Diabetes Technology and Therapeutics

Volumn 8, Issue 6, 2006, Pages 609-616

  Yeldandi, Renuka R ^a   Lurie, Alexander ^a   Baldwin, David ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 33845331739     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.609     Document Type: Article

References (31)

1. Van den Berghe G, Wouters P, Verwaest C, Bruyninckx F, Schetz P, Vlasselaers D, Ferdinade P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
2. Pittas AG, Siegal RD, Lau J: Insulin therapy for critically ill hospitalized patients. Arch Intern Med 2004;164:2005-2011.
3. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continous intravenous insulin infusion reduces the incidence of deep sternal would infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-362.
4. Furnary AP, Gao G, Grunkmeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-1021.
5. Spelman DW, Russo P, Harrington G, Davis BB, Rabinov M, Smith JA, Spicer WJ, Esmore D: Risk factors for surgical wound infection and bacteremia following coronary artery bypass surgery. Aust N Z J Surg 2000;70:47-51.
6. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
7. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ: The relationship between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-815.
8. Bhatia V, Wilding GE, Dhindsa G, Bhatia R, Garg RK, Bonner AJ, Dhindsa S: Association of poor glycemic control with prolonged hospital stay in patients with diabetes admitted with exacerbation of congestive heart failure. Endocr Pract 2004;10:467-471.
9. Standards of medical care in diabetes: American Diabetes Association. Diabetes Care 2006;29(Suppl 1):S4-S42.
10. Quale WS, Seidler AJ, Brancati FL: Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157:545-552.
11. Gearhart JG, Duncan JI, Replogle WH, Forbes RC, Walley EJ: Efficacy of sliding-scale insulin therapy: a comparison with prospective regimens. Fam Pract Res J 1994;14:313-322.
12. Baldwin D, Villanueva G, McNutt R, Bhatnagar S: Eliminating inpatient sliding-scale insulin. Diabetes Care 2005;28:1008-1011.
13. Hirsch IB: Insulin analogues. N Engl J Med 2005;352:173-183.
14. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A: Reduced hypoglycemic risk with insulin glargine. Diabetes Care 2005;28:950-955.
15. Riddle MC, Rosenstock J, Gerich J: The treat to target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-3086.
16. Yeldandi RR, Lurie A, Baldwin D: Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery [abstract]. Diabetes 2005;54(Suppl 1):512.
17. Hurst RT, Lee RW: Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 2003;139:824-834.
18. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE: Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002;25:1129-1148.
19. Ghandi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, Schrader LM, Rizza RA, McMahon MM: Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005;80:862-866.
20. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schaffer RG, Hirsch IB: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553-591.
21. Bode BW, Braithwaite SS, Steed RD, Davidson PC: Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004;10(Suppl 2):71-80.
22. Magee MF, Clement S: Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract 2004;10(Suppl 2):81-88.
23. ACE Task Force on Inpatient Diabetes and Metabolic Control: American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004;10(Suppl 2):4-9.
24. ACE Consensus Development Conference: Improving Inpatient Diabetes Care: A Call to Action Conference January 30 and 31, 2006. Available at: http://www.aace.com/meetings/consensus/IIDC/ (accessed June 25, 2006).
25. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE: Unrecognized diabetes among hospitalized patients. Diabetes Care 1998;21:246-249.
26. Roman SH, Chassin MR: Windows of opportunity to improve diabetes care when patients with diabetes are hospitalized for other conditions. Diabetes Care 2001;24:1371-1376.
27. Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, Nawaz H: Utility of HBA1C levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003;2003;26:1064-1068.
28. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe MR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-431.
29. Corpus RA, O'Neill WW, Dixon SR, Timmis GC, Devlin WH: Relation of hemoglobin A1C to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol 2003;92:1282-1286.
30. Cato T, Gao SZ, Schroeder JS, Yokota M, Murohara T, Iwase M, Noda A, Hunt SA, Valantine HA: Glucose intolerance, as reflected by hemoglobin A1C level, is associated with the incidence and severity of transplant coronary artery disease. J Am Coll Cardiol 2004;43:1034-1041.
31. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1C with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004;141:413-420.